viral vectors

spray painting
Biotech

BMS-backed Dispatch unveils with $216M, Carl June as cofounder

Dispatch's two-pronged approach has clearly impressed investors. Since 2022, the biotech has raised $216 million in both seed and series A money.
Gabrielle Masson Jul 23, 2025 6:30am
FDA
Favicon Fierce Pharma

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am
Redbrick building with Sarepta name and logo
Favicon Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
gene therapy AAV adeno-associated viruses

Neurogene details death in Rett syndrome gene therapy trial

May 16, 2025 3:00pm
AAV virus capsid

Vertex discontinues AAV research for gene therapies

May 2, 2025 6:22pm
Black phone dangling by cord in phonebooth

Ring lays off nearly half of staff, CEO to exit in new year

Dec 18, 2024 2:31pm